PRELUDE THERAPEUTICS INC: Ownership & Insider Activity
Hedge funds and institutional managers reporting a position in PRELUDE THERAPEUTICS INC. Based on the most recent 13F filing from each holder, sourced from SEC EDGAR.
Reported Holders
6
13F filers
Aggregate Value
$30.3M
Across holders
Last Price
—
EOD close
Sector
—
GICS
| Manager⇅ | Type⇅ | Shares⇅ | Market Value▼ | % of Total⇅ | % of Portfolio⇅ | Action⇅ | QoQ Change⇅ | Quarter⇅ |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC CIK 0001055951 | Hedge Fund | 5.68M | $30.3M | 100.0% | 0.6% | Unchanged | +$0 | Q2 2026 |
| TWO SIGMA ADVISERS, LP CIK 0001478735 | Hedge Fund | 0 | $0 | 0.0% | 0.0% | Unchanged | +$0 | Q2 2026 |
| EMINENCE CAPITAL LLC CIK 0001107310 | Hedge Fund | 0 | $0 | 0.0% | 0.0% | New | — | Q2 2026 |
| Matrix Capital Management Company, LP CIK 0001410830 | Hedge Fund | 0 | $0 | 0.0% | 0.0% | New | — | Q2 2026 |
| Mantle Ridge LP CIK 0001695459 | Hedge Fund | 0 | $0 | 0.0% | 0.0% | New | — | Q2 2026 |
| ELLIOTT MANAGEMENT CORP CIK 0001048445 | Hedge Fund | 0 | $0 | 0.0% | 0.0% | New | — | Q3 2020 |
Unchanged
Hedge Fund
$30.3M· 100.0% of total· 0.6% port· 5.68M sh· +$0 QoQ· Q2 2026
Unchanged
Hedge Fund
$0· 0.0% of total· 0.0% port· 0 sh· +$0 QoQ· Q2 2026
New
Hedge Fund
$0· 0.0% of total· 0.0% port· 0 sh· — QoQ· Q2 2026
New
Hedge Fund
$0· 0.0% of total· 0.0% port· 0 sh· — QoQ· Q2 2026
New
Hedge Fund
$0· 0.0% of total· 0.0% port· 0 sh· — QoQ· Q2 2026
New
Hedge Fund
$0· 0.0% of total· 0.0% port· 0 sh· — QoQ· Q3 2020